These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 557157)

  • 61. Serotonin: a possible mediator of behavioral suppression induced by anxiety.
    Wise CD; Berger BD; Stein L
    Dis Nerv Syst; 1970 Nov; 31():Suppl:34-7. PubMed ID: 5312689
    [No Abstract]   [Full Text] [Related]  

  • 62. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effect of vagotomy and lysergic acid diethylamide (LSD) on ulcerogenic action of phenylbutazone and reserpine in rats with regard to the role of 5-hydroxytryptamine (author's transl)].
    Kohút A; Nicák A
    Bratisl Lek Listy; 1977 Sep; 68(3):336-43. PubMed ID: 912454
    [No Abstract]   [Full Text] [Related]  

  • 64. [Shock-induced aggression and reactivity following raphe lesion in rats. Effects of physostigmine (author's transl)].
    Vergnes M; Penot C
    Brain Res; 1976 Mar; 104(1):107-19. PubMed ID: 942879
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanisms of action of LSD.
    Jacobs BL; Trulson ME
    Am Sci; 1979; 67(4):396-404. PubMed ID: 533027
    [No Abstract]   [Full Text] [Related]  

  • 66. RNA synthesis in isolated brian nuclei after administration of d-lysergic acid diethylamide (LSD) in vivo.
    Brown IR
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):837-9. PubMed ID: 1055380
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chronic lysergic acid diethylamide administration and serotonin turnover in various regions of the rat brain.
    Peters DA
    J Neurochem; 1974 Oct; 23(4):625-8. PubMed ID: 4430908
    [No Abstract]   [Full Text] [Related]  

  • 68. Relationship between alteration of the cholinergic system and behavioral effects of LSD in rats.
    Kabes J; Fink Z
    Act Nerv Super (Praha); 1970; 12(3):261. PubMed ID: 5457449
    [No Abstract]   [Full Text] [Related]  

  • 69. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Contribution to serotonin theory of dreaming (LSD infusion).
    Torda C
    N Y State J Med; 1968 May; 68(9):1135-8. PubMed ID: 5239970
    [No Abstract]   [Full Text] [Related]  

  • 71. Effects of chlorimipramine and lysergic acid diethylamide on efflux of precursor-formed 3-H-serotonin: correlations with serotonergic impulse flow.
    Gallager DW; Aghajanian GK
    J Pharmacol Exp Ther; 1975 Jun; 193(3):785-95. PubMed ID: 168347
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ca2+ channel blockade prevents lysergic acid diethylamide-induced changes in dopamine and serotonin metabolism.
    Antkiewicz-Michaluk L; Románska I; Vetulani J
    Eur J Pharmacol; 1997 Jul; 332(1):9-14. PubMed ID: 9298920
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Actions of D-lysergic acid diethylamide (LSD) and its derivatives on 5-hydroxytryptamine receptors in the isolated uterine smooth muscle of the rat.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Eur J Pharmacol; 1977 Oct; 45(4):341-8. PubMed ID: 923645
    [No Abstract]   [Full Text] [Related]  

  • 74. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
    Winter JC
    J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
    [No Abstract]   [Full Text] [Related]  

  • 76. An inhibition of post-ganglionic motor transmission in the mammalian vas deferens by D-lysergic acid diethylamide.
    Ambache N; Dunk LP; Verney J; Zar MA
    J Physiol; 1973 Jun; 231(2):251-70. PubMed ID: 4352765
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [D-Lysergic acid diethylamide (LSD). 2. Clinical aspects].
    GROF S; VOJTECHOVSKY M; VOTAVA Z
    Lek Veda Zahr; 1960; 11():245-51 contd. PubMed ID: 13858660
    [No Abstract]   [Full Text] [Related]  

  • 78. Mescaline and LSD: direct and indirect effects on serotonin-containing neurons in brain.
    Haigler HJ; Aghajanian GK
    Eur J Pharmacol; 1973 Jan; 21(1):53-60. PubMed ID: 4709205
    [No Abstract]   [Full Text] [Related]  

  • 79. Interaction between narcotic antagonist (naloxone) and lysergic acid diethylamide (LSD) in the rat.
    Fertziger AP; Fischer R
    Psychopharmacology (Berl); 1977 Nov; 54(3):313-4. PubMed ID: 413151
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of LSD-25 on brain serotonin.
    FREEDMAN DX
    J Pharmacol Exp Ther; 1961 Nov; 134():160-6. PubMed ID: 13894866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.